In conclusion, we have defined a NGS protocol based on the 454 GS-Junior platform for the analysis of EGFR and validated it with unselected limited tumor samples routinely submitted for molecular diagnosis to three different Italian laboratories. Here, EGFR is linked to neoplasm.